Dog Arthritis Injections: Every Option Explained and Which Is Safest

Your dog has arthritis. Your vet has mentioned injections — or perhaps you have been Googling at night and found a confusing mix of options: Librela, Adequan, steroid shots, PRP, stem cells. Some cost hundreds, some thousands. Some need to be done weekly, some monthly. And nobody seems to have explained clearly what each one actually does, which is safest, or how to choose.

That is what this guide is for. I am going to walk you through every significant injection option for dog arthritis — what each one does, what the evidence says, what the real-world risks are, and which dogs are most likely to benefit from each. By the end you will understand the landscape well enough to have a proper conversation with your vet about which approach makes sense for your specific dog.

One important thing upfront: the best arthritis management in dogs almost always involves more than one approach working together. The research consistently shows that a multi-modal plan — combining pain relief with joint protection with targeted exercise — produces better outcomes than any single injection alone. Think of each injection as one tool in a toolbox, not a complete solution.

Understanding What Arthritis Injections Are Trying to Do

Before comparing specific options, it helps to understand that different injections are trying to do fundamentally different things. Some target pain — they reduce how much pain your dog feels, but do not change what is happening in the joint. Others target the joint itself — they protect cartilage, reduce inflammation locally, or promote repair. Some newer treatments try to do both.

This distinction matters because a dog on pain relief only is a dog who feels better but whose joint continues to deteriorate. A dog on joint-protective treatment may be slower to see benefit but may have less joint damage over time. The best protocols combine both — fast-acting pain control while the joint-protective treatment builds up.

Adequan (Polysulfated Glycosaminoglycan) — The Joint Protector

Adequan is one of the most established injectable arthritis treatments in veterinary medicine and has been in use for decades. Adequan is an injectable polysulfated glycosaminoglycan — mostly chondroitin sulfate — which serves not only as a cartilage component used in healing but as an actual anti-inflammatory agent. Adequan has numerous beneficial effects for the arthritis patient, including the inhibition of harmful enzymes involving joint cartilage destruction, stimulation of cartilage repair, and increasing joint lubrication.

Unlike most arthritis medications which simply mask pain, Adequan actually targets the disease process itself. It slows the breakdown of cartilage and actively supports its repair. Adequan is very safe and has few side effects. Not only does it relieve pain, it also helps repair joint cartilage, improving joint function and mobility over time.

How it is given

Dogs typically receive eight intramuscular shots over one month — two per week for four weeks. If your dog is still experiencing pain after this loading course, your vet may decide to repeat the series the following month. After the loading phase, Adequan is given on an as-needed basis for maintenance.

How quickly it works

Adequan usually shows changes such as a steadier stride and greater freedom of movement within two to four weeks of starting treatment. It is particularly suitable for dogs that need relief, especially when arthritis is just beginning to affect quality of life. However, its full effect takes time to build up.

Who it is best for

Adequan is particularly valuable in early to moderate arthritis, where preserving remaining cartilage makes the biggest long-term difference. It is also a strong option for dogs who cannot tolerate NSAIDs due to stomach, kidney, or liver issues, since it works through a completely different mechanism. It can safely be combined with NSAIDs, Librela, and joint supplements.

Safety profile

Adequan has an excellent safety record built over decades of use. Side effects are uncommon and generally mild — occasional injection site reactions. It does not carry the organ toxicity risks of NSAIDs and does not require the same level of monitoring.

Librela (Bedinvetmab) — The Monthly Pain Blocker

Librela is the newest addition to this list and arguably the most significant development in canine arthritis pain management in years. Unlike every other option here, it works not on the joint or on inflammation, but directly on the pain signalling pathway itself.

Librela contains bedinvetmab, a canine-specific monoclonal antibody that binds to a protein called Nerve Growth Factor (NGF). NGF is a key driver in the transmission of pain signals, and its levels are elevated in dogs with osteoarthritis. By neutralising NGF, Librela interrupts the pain signalling pathway at its source, preventing pain signals from reaching the brain.

The result is that dogs feel less pain — not because the joint is less inflamed or better lubricated, but because the pain message from the joint to the brain is being intercepted. This is why Librela can work in dogs who have not responded to NSAIDs: it is working at a completely different step in the process.

How it is given

A single subcutaneous injection given by your vet once every four weeks. The dose is calculated by body weight. It cannot be given at home.

How quickly it works

Some dogs show improvement within days to two weeks. For others it takes more than a month. Two injections before judging effectiveness is the standard recommendation.

Important limitation

Librela does not reduce inflammation or directly improve joint function. It simply prevents your dog from feeling the pain associated with arthritis. So it is not appropriate as a standalone OA treatment plan — it is best used as part of a comprehensive approach.

Who it is best for

Librela is particularly beneficial for geriatric dogs with concurrent kidney, liver, or gastrointestinal disease who are poor candidates for NSAIDs, dogs who failed traditional therapy and did not respond to or could not tolerate daily oral medications, and dogs needing long-term pain management where once-monthly administration improves compliance.

Safety considerations

The FDA has received and reviewed post-marketing adverse event reports including neurological signs, urinary changes, and rare immune reactions. The ideal candidate for Librela has uncomplicated osteoarthritis — meaning overall the dog is healthy and does not have concurrent health issues, most notably neurological symptoms or conditions. Dogs with intervertebral disc disease, degenerative myelopathy, or lumbosacral stenosis are generally not suitable candidates.

Corticosteroid Injections — Fast Relief With Significant Caveats

Corticosteroid injections — using drugs such as prednisone, methylprednisolone, or triamcinolone — are among the most powerful anti-inflammatory treatments available and can produce rapid, dramatic relief from arthritis pain. Steroid shots can provide rapid and powerful relief, often within a day.

However, they come with important limitations that make them generally a short-term rather than long-term solution for arthritis in dogs.

Unfortunately, steroids can harm cartilage and actually contribute to worsening osteoarthritis when used repeatedly. This is the central problem: the same drug that provides rapid pain relief can, with repeated use, accelerate the very joint damage it is treating. For this reason, most veterinary orthopaedic specialists limit corticosteroid joint injections to no more than three or four per joint per year, and many recommend spacing them at least three to four months apart.

Steroids and NSAIDs should never be used together as this can lead to serious side effects such as stomach ulceration. Always tell your veterinarian what medications your dog is on before adding steroids to the protocol.

When corticosteroids are most appropriate

Short-term management of a severe acute flare-up where rapid relief is the priority, in a dog who cannot tolerate other options. As a bridge while a longer-term plan is established. For specific localised joint problems where targeted intra-articular injection is more appropriate than systemic medication. Not as a first-line or long-term arthritis management strategy in most cases.

Platelet-Rich Plasma (PRP) — Regenerative Therapy

PRP therapy involves drawing a small amount of the patient's blood, separating the red and white blood cells, leaving behind the plasma and platelets, and injecting the platelet-rich solution into the affected joint. These platelets contain growth factors that stimulate tissue repair and reduce inflammation.

PRP uses the body's own healing mechanisms, concentrated and delivered directly to the affected joint. There is a growing evidence base supporting its use in canine arthritis, though the research is less extensive than for Adequan or Librela. The main advantages are that it uses the dog's own blood — so there is no risk of allergic reaction or foreign substance rejection — and it actively promotes tissue repair rather than simply masking symptoms.

PRP is typically administered as one to three injections into the affected joint under sedation. The procedure requires specialist equipment to process the blood and expertise to inject accurately into the joint, so it is generally performed at specialist or referral centres rather than general practice.

Stem Cell Therapy — Cutting Edge, Still Evolving

Stem cell therapy involves harvesting stem cells — either from the dog's own fat tissue or bone marrow, or from donor sources — processing them, and injecting them into affected joints. Stem cell therapy harnesses the dog's own stem cells to regenerate damaged joint tissues. These cells can transform themselves into specialised cells, promoting tissue repair and regrowth.

The evidence base for stem cell therapy in canine arthritis is still developing, and it remains more expensive and less widely available than the other options on this list. However, for dogs with significant joint damage where other approaches have provided inadequate relief, it represents a genuinely different approach with the potential for more meaningful joint repair.

The procedure typically involves a short surgical procedure to harvest fat tissue, processing at a specialist laboratory, and injection into the affected joints, usually under sedation. It is performed at specialist or university veterinary centres.

Cartrophen Vet (Pentosan Polysulfate) — The Widely Used International Option

Cartrophen Vet is an injectable medication used in dogs to manage osteoarthritis. It is not a pain medication or NSAID. It is approved in Australia, Canada, and the UK, but not currently approved in the US for dogs — though it is approved in the US for horses and humans, and can be used off-label.

Like Adequan, Cartrophen works on the joint itself — stimulating cartilage repair, reducing inflammation, and improving joint fluid quality — rather than simply blocking pain. It is administered as a series of weekly injections initially. Many owners and vets in countries where it is available report good long-term results with an excellent safety profile.

If you are in the UK, Australia, or Canada and your vet has recommended or mentioned Cartrophen, it occupies a similar position to Adequan — joint protection and disease modification rather than pure pain relief.

Which Injection Is Safest for Dogs with Arthritis?

This is the question your Search Console says owners are asking most — and it deserves a direct answer.

From a pure safety perspective, Adequan has the longest track record and the most reassuring long-term safety data. It has been in use for decades, the side effect profile is well understood, and serious adverse events are uncommon. For a dog with uncomplicated arthritis and no specific contraindications, Adequan is often the safest starting point for injectable treatment.

Librela has a strong safety profile in the clinical trial setting, but the real-world adverse event reports — particularly neurological and urinary effects — mean it requires more careful patient selection and monitoring. It is very safe for the right dog; it carries more risk for dogs with pre-existing neurological, urinary, or immune conditions.

Corticosteroid injections are effective short-term but carry the most risk with repeated use — cartilage damage, systemic steroid effects, and interaction risks with other medications.

PRP and stem cell therapy use the dog's own biological material, making foreign substance reactions unlikely — but they are newer, less standardised, and more expensive, with a developing rather than established evidence base.

Can These Injections Be Combined?

Yes — and in many cases combining them produces significantly better outcomes than using one alone.

Librela gives pain relief immediately — pain is blocked at the nerve level and the dog starts moving more comfortably. Adequan is protecting and rebuilding cartilage — but takes weeks to work. The dog does not feel Adequan working, but imaging months later shows less progression than expected. Together, the dog gets pain relief now while the joint is being actively protected.

The combination most supported by current evidence for moderate to severe arthritis is Adequan plus Librela, potentially alongside an NSAID or gabapentin depending on the individual dog's pain levels and tolerance. Corticosteroids should not be combined with NSAIDs. Librela, Adequan, NSAIDs, and gabapentin can generally be safely used together under veterinary supervision.

A Practical Guide — Which Injection for Which Situation

For early arthritis in an otherwise healthy dog: Adequan loading series plus joint supplements and weight management. Excellent safety, addresses disease progression, not just pain.

For moderate arthritis with inadequate pain control on supplements alone: Add an NSAID (meloxicam or carprofen) alongside Adequan, or consider introducing Librela if NSAID tolerance is a concern.

For a dog who cannot tolerate NSAIDs due to kidney, liver, or stomach disease: Librela is a strong choice — it works through a completely different mechanism and does not carry the organ risks of NSAIDs. Adequan alongside it provides joint protection.

For severe arthritis with significant pain despite NSAIDs: Consider adding Librela to existing treatment, reassess weight management, discuss physiotherapy, and potentially explore PRP or stem cell therapy at a specialist centre.

For a short-term severe flare: A single corticosteroid injection can provide rapid, dramatic relief as a bridge — but this should not become the long-term plan.

Questions to Ask Your Vet Before Choosing an Injection

• What stage is my dog's arthritis? (X-ray-based staging changes the treatment recommendation significantly)

• Does my dog's health history make any of these options higher risk — particularly kidney, liver, neurological, or immune conditions?

• Are we treating pain only, or also trying to slow joint damage? (This affects whether Adequan, Librela, or both are most appropriate)

• Can these injections be used alongside my dog's other current medications?

• What monitoring will we do and how often?

• What do we do if the first approach doesn't work well enough?

A Final Word from Dr. Waleed

The landscape of injectable arthritis treatment for dogs has changed significantly in the last few years — Librela in particular has added something genuinely new to a toolkit that was previously limited to Adequan, steroids, and oral medications. For many dogs with arthritis, the combination of Adequan for joint protection and Librela for pain control has produced results that were difficult to achieve before.

But the most important thing I can tell you is that there is no single right answer. The best injection for your dog depends on how severe their arthritis is, what other conditions they have, what they have already tried, what their organ function looks like on bloodwork, and what your long-term goals are. These are not choices to make from a Google search alone — they are conversations to have with your vet, armed with the right questions.

What I hope this guide gives you is the understanding to have that conversation properly — to know what each option does, what its real limitations are, and what combination might make most sense for your dog specifically. That conversation, done well, makes a measurable difference to how many good years your dog has ahead of them.

Frequently Asked Questions

Is there a shot for dogs with arthritis?

Yes — there are several, and they work in very different ways. The main options are Adequan, which protects cartilage and supports joint repair; Librela, a monthly injection that blocks pain signals; corticosteroid injections, which reduce inflammation rapidly but have risks with long-term use; and newer regenerative options like PRP and stem cell therapy. Many dogs with moderate to severe arthritis benefit from a combination of more than one approach. Your vet can advise which options are most appropriate for your dog's specific situation and health history.

What is the safest arthritis injection for dogs?

Adequan has the longest track record and most reassuring long-term safety data of the established options — it has been used for decades with an excellent safety profile and few serious adverse events. Librela is safe for most dogs but requires more careful patient selection, particularly avoiding dogs with pre-existing neurological or urinary conditions. Corticosteroid injections are effective short-term but carry the most concerns with repeated use. PRP uses the dog's own blood, making it biologically very safe, though the evidence base is less established. The safest option for your specific dog depends on their individual health history.

What is the difference between Librela and Adequan?

They work completely differently and are not in competition — they complement each other. Librela blocks pain signals by targeting a protein called NGF, so dogs feel less pain. It does not change what is happening in the joint itself. Adequan works directly on the joint — it inhibits cartilage-destroying enzymes and promotes cartilage repair. It takes longer to see results but is actually changing the disease process. Many vets now use both together: Librela for pain relief and Adequan to protect the joint from further damage.

How long do dog arthritis injections last?

It depends on the type. Librela is a monthly injection — pain control lasts approximately 30 days. Adequan requires a loading course of eight injections over four weeks, then maintenance on an as-needed basis — individual dogs vary in how long they stay comfortable between maintenance doses. Corticosteroid joint injections typically provide relief for four to eight weeks, though this varies. PRP and stem cell therapy may provide longer-lasting benefit — sometimes six months to a year or more — but individual responses vary significantly.

Can I give my dog arthritis injections at home?

It depends on the type. Adequan can be given at home once your vet has demonstrated the correct technique — it is an intramuscular injection and some owners do administer the maintenance doses themselves. Librela must be given by a vet at the clinic — this is intentional, allowing monitoring of the dog's response. Corticosteroid joint injections and PRP require specialist skills and cannot be given at home. Your vet will advise on which options, if any, may be suitable for home administration for your dog.

Are arthritis injections better than tablets for dogs?

Not necessarily better — different. Injections bypass the digestive system and deliver medication directly where it is needed, which can be more effective for some purposes and avoids the need for daily tablet battles. Adequan can only be given by injection, not orally. Librela is specifically designed as an injectable monoclonal antibody — it cannot be given as a tablet. For dogs who are difficult to medicate orally, or whose stomachs cannot tolerate daily NSAID tablets, injections can be genuinely transformative. But oral NSAIDs remain highly effective for many dogs and should not be dismissed simply because injections sound more advanced.

Can Librela and Adequan be given at the same time?

Yes, and this combination is increasingly used in clinical practice for dogs with moderate to severe arthritis. Librela provides pain relief by blocking pain signals, while Adequan works on the joint itself to protect cartilage and support repair. The two work through completely different mechanisms, making them complementary rather than redundant. They can also be combined with NSAIDs and gabapentin under veterinary supervision. Many vets and specialists consider the Librela plus Adequan combination one of the most effective approaches for significant arthritis pain in senior dogs.

How much do dog arthritis injections cost?

Costs vary significantly depending on your location, the size of your dog, and which option you choose. Adequan loading series typically costs between £150 and £400 (or equivalent) for the initial eight-injection course, then lower maintenance costs. Librela monthly injections cost approximately £50 to £150 per month depending on your dog's weight and your location. Corticosteroid joint injections are generally less expensive per injection. PRP and stem cell therapy are the most expensive options — often £500 to £2,000 or more per treatment course at specialist centres. Costs should always be weighed against the benefit — better pain control means better mobility, less secondary muscle wasting, and often a longer healthy lifespan.

Ask Dr. Waleed

Have a question about arthritis injections or pain management for your senior dog? Send Dr. Waleed a message — I read every question and answer as many as I can.

Related Posts

• Librela (Bedinvetmab) Injection for Dogs: Side Effects, How It Works and What Owners Need to Know

• Signs of Arthritis in Senior Dogs: What Most Owners Miss